Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Masamune Hiroko
 2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2018		 3. Issuer Name and Ticker or Trading Symbol
Viking Therapeutics, Inc. [VKTX]
(Last)
(First)
(Middle)
12340 EL CAMINO REAL, SUITE 250		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Development Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN DIEGO, CA 92130		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.00001 per share (1) 96,197
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (2) 01/19/2028 Common Stock 35,000 $ 4.65 D  
Stock Option (Right to Buy)   (3) 06/30/2027 Common Stock 18,000 $ 1.08 D  
Stock Option (Right to Buy)   (4) 01/05/2027 Common Stock 30,000 $ 1.23 D  
Stock Option (Right to Buy)   (5) 06/30/2026 Common Stock 13,500 $ 1.26 D  
Stock Option (Right to Buy)   (6) 03/04/2026 Common Stock 9,800 $ 2.15 D  
Stock Option (Right to Buy)   (7) 05/04/2025 Common Stock 18,000 $ 9.49 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Masamune Hiroko
12340 EL CAMINO REAL, SUITE 250
SAN DIEGO, CA 92130		       Chief Development Officer  

Signatures

/s/ Michael Morneau, as Attorney-in-Fact 07/03/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 10,000 shares subject to a restricted stock unit award ("RSU") of common stock that was granted on 1/19/2018 under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
(2) 25% of the shares subject to the option will vest on each one year anniversary of the grant date of January 19, 2018.
(3) 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date of June 30, 2017.
(4) 25% of the original 40,000 shares subject to the option vested or will vest on each one year anniversary of the grant date of January 5, 2017.
(5) 25% of the original 18,000 shares subject to the option vested or will vest on each one year anniversary of the grant date of June 30, 2016.
(6) 25% of the original 19,600 shares subject to the option vested or will vest on each one year anniversary of the grant date of March 4, 2016.
(7) 25% of the shares subject to the option were vested upon the grant date of May 4, 2015 and 25% of the shares subject to the option vested on each one year anniversary of the grant date.
 
Remarks:
Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.